Jeff Yass’s Nutex Health NUTX Stock Holding History

Jeff Yass’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$420K	Buy	2,457 +36	+1%	+$4.56K	﹤0.01%	10303
2026 Q1	$230K	Sell	2,421 -1,899	-44%	-$233K	﹤0.01%	11436
2025 Q4	$711K	Buy	+4,320	New	+$573K	﹤0.01%	7986
2025 Q3	–	Sell	-7,850	Closed	-$977K	–	13436
2025 Q2	$977K	Sell	7,850 -43,650	-85%	-$5.64M	﹤0.01%	7494
2025 Q1	$2.42M	Buy	+51,500	New	+$2.51M	﹤0.01%	5111
2024 Q3	–	Sell	-1,148	Closed	-$6.83K	–	12704
2024 Q2	$6.83K	Buy	+1,148	New	+$8.28K	﹤0.01%	11805
2024 Q1	–	Sell	-758	Closed	-$20.5K	–	12965
2023 Q4	$20.5K	Buy	+758	New	+$23.6K	﹤0.01%	11972
2023 Q3	–	Sell	-702	Closed	-$44.4K	–	12654
2023 Q2	$44.4K	Buy	702 +2	+0.3%	+$172	﹤0.01%	11383
2023 Q1	$106K	Buy	+700	New	+$142K	﹤0.01%	11247
2022 Q4	–	Sell	-77	Closed	-$17K	–	13283
2022 Q3	$17K	Sell	77 -115	-60%	-$48.8K	﹤0.01%	12652
2022 Q2	$93K	Buy	+192	New	+$226K	﹤0.01%	11542

Other funds holding NUTX

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Jeff Yass's NUTX Position: Q2 2026 in Review

Jeff Yass increased its Nutex Health (NUTX) stake by 1.5% in Q2 2026, buying an estimated $4.56K and bringing the position to 2,457 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #10303.

Jeff Yass first reported a position in NUTX in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.42M in Q1 2025. 152 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

Jeff Yass held 2,457 shares of Nutex Health worth $420K as of Q2 2026.
Jeff Yass bought 36 Nutex Health shares in Q2 2026, an estimated $4.56K.
Nutex Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10303 holding.
Jeff Yass first reported a position in Nutex Health in Q2 2022 and has held it in 11 quarters since.
Jeff Yass's Nutex Health position peaked at $2.42M in Q1 2025.
152 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.